Misuse of Drugs (Controlled Drugs) Order 1996
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
COMMENCEMENT DAY NOTICE 1993
1989 Revision 1
AG13/69B-GG/sd 04/08/05
BR 33/1996
MISUSE OF DRUGS ACT 1972
1972 : 159
THE MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
The Minister of Health and Social Services, in exercise of the
powers conferred upon him by subsection (2) of section 3 of the Misuse
of Drugs Act 1972, makes the following Order after consultation with the
Advisory Board on the Misuse of Drugs:
Citation
1 This Order may be cited as the Misuse of Drugs (Controlled
Drugs) Order 1996.
Amendment of Schedule 2 to Act No 159 of 1972
2 Part I of Schedule 2 to the Misuse of Drugs Act 1972 is deleted
and the new Part I set forth in the Schedule to this Order is substituted.
Commencement
3 This Order comes into operation on the date of commencement
of the Criminal Justice (International Co-operation) (Bermuda) Act 1994.
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
2 1989 Revision
SCHEDULE (Paragraph 2)
PART I
1. The following substances and products, namely:-
(a) ACETORPHINE
ACETYLDIHYDROCODEINE
ALFENTANIL
ALLYLPRODINE
ALPHACETYLMETHADOL
ALPHAMEPRODINE
ALPHAMETHADOL
ALPHAPRODINE
ALPRAZOLAM
AMPHETAMINE
ANILERIDINE
BENZETHIDINE
BENZPHETAMINE
BENZYLMORPHINE (3-Benzylmorphine)
BETACETYLMETHADOL
BETAMEPRODINE
BETAMETHADOL
BETAPRODINE
BEZITRAMIDE
BROMAZEPAM
BUFOTENINE
BUPRENORPHINE
CAMAZEPAM
CANNABINOL DERIVATIVES
CANNABINOL except where contained in Cannabis or
Cannabis resin
CANNABIS AND CANNABIS RESIN
CARFENTANIL
CATHINE
CATHINONE
CHLORDIAZEPOXIDE
CHLORPHENTERMINE
CLOBAZAM
CLONAZEPAM
CLONITAZENE
CLORAZEPIC ACID
CLOTIAZEPAM
CLOXAZOLAM
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
COMMENCEMENT DAY NOTICE 1993
1989 Revision 3
COCA LEAF
COCAINE
CODEINE
DELORAZEPAM
DESOMORPHINE
DEXTROMORAMIDE
DEXTROPROPOXYPHENE
DIAMORPHINE
DIAMPROMIDE
DIAZEPAM
DIETHYLPROPION
DIETHYLTHIAMBUTENE
DIFENOXIN (1-(3-cyano-3,3-diphenylpropyl)-4-
phenylpiperidine-4-carboxylic acid)
DIHYDROCODEINE
DIHYDROCODEINONE O-CARBOXYMETHYLOXIME
DIHYDROMORPHINE
DIMENOXADOLE
DIMEPHEPTANOL
DIMETHYLTHIAMBUTENE
DIOXAPHETYL BUTYRATE
DIPHENOXYLATE
DIPIPANONE
DROTEBANOL (3,4-dimethoxy-17-methylmorphinan-
6,14-diol)
ECGONINE and any derivative of ecgonine which is
convertible to ecgonine or to cocaine
ESTAZOLAM
ETHCHLORVYNOL
ETHINAMATE
ETHYL LOFLAZEPATE
ETHYLMETHYLTHIAMBUTENE
ETHYLMORPHINE (3-ethylmorphine)
ETICYCLIDINE
ETONITAZENE
ETORPHINE
ETOXERIDINE
FENCANFAMIN
FENETHYLLINE
FENPROPOREX
FENTANYL
FLUDIAZEPAM
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
4 1989 Revision
FLUNITRAZEPAM
FLURAZEPAM
FURETHIDINE
GLUTETHIMIDE
HALAZEPAM
HALOXAZOLAM
HYDROCODONE
HYDROMORPHINOL
HYDROMORPHONE
HYDROXYPETHIDINE
ISOMETHADONE
KETAZOLAM
KETOBEMIDONE
LEFETAMINE
LEVOMETHORPHAN
LEVOMORAMIDE
LEVOPHENACYLMORPHAN
LEVORPHANOL
LOFENTANIL
LOPRAZOLAM
LORAZEPAM
LORMETAZEPAM
LYSERGAMIDE
LYSERGIDE and other N-alkyl derivatives of lysergamide
MAZINDOL
MECLOQUALONE
MEDAZEPAM
MEFENOREX
MEPHENTERMINE
MEPROBAMATE
MESCALINE
METAZOCINE
METHADONE
METHADYL ACETATE
METHAQUALONE
METHYLAMINOREX
METHYLAMPHETAMINE
METHYLDESORPHINE
METHYLDIHYDROMORPHINE (6-methyldihydromorphine)
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
COMMENCEMENT DAY NOTICE 1993
1989 Revision 5
METHYLPHENIDATE
METHYLPHENOBARBITONE
METHYPRYLONE
METOPON
MIDAZOLAM
MORPHERIDINE
MORPHINE
MORPHINE METHOBROMIDE, morphine n-oxide and other
pentavalent nitrogen morphine derivatives
MYROPHINE
N, N-DIETHYLTRYPTAMINE
N, N-DIMETHYLTRYPTAMINE
N-ETHYLAMPHETAMINE
N-HYDROXYTENAMPHETAMINE (N-hydroxy MDA)
NICOCODINE
NICODICODINE (6-nicotinoyldihydrocodeine)
NICOMORPHINE (3,6-dinicotinoylmorphine)
NIMETAZEPAM
NITRAZEPAM
NORACYMETHADOL
NORCODEINE
NORDIAZEPAM
NORLEVORPHANOL
NORMETHADONE
NORMORPHINE
NORPIPANONE
OPIUM whether raw, prepared or medicinal
OXAZEPAM
OXAZOLAM
OXYCODONE
OXYMORPHONE
PEMOLINE
PENTAZOCINE
PETHIDINE
PHENADOXONE
PHENAMPROMIDE
PHENAZOCINE
PHENCYCLIDINE
PHENDIMETRAZINE
PHENMETRAZINE
PHENOMORPHAN
PHENOPERIDINE
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
6 1989 Revision
PHENTERMINE
PHOLCODINE
PIMINODINE
PINAZEPAM
PIPRADROL
PIRITRAMIDE
POPPY-STRAW and concentrate of poppy-straw
PRAZEPAM
PROHEPTAZINE
PROPERIDINE (1-methyl-4-phenylpiperidine-4-carboxylic
acid isopropyl ester)
PROPIRAM
PROPYLHEXEDRINE
PSILOCIN
PYROVALERONE
RACEMETHORPHAN
RACEMORAMIDE
RACEMORPHAN
ROLYCYCLIDINE
SUFENTANIL
TEMAZEPAM
TENOCYCLIDINE
TETRAZEPAM
THEBACON
THEBAINE
TILIDATE
TRIAZOLAM
TRIMEPERIDINE
4-BROMO-2,5-DIMETHOXY--METHYLPHENETHYLAMINE
4-CYANO-2-DIMETHYLAMINO-4,4-DIPHENYLBUTANE
4-CYANO-1-METHYL-4-PHENYLPIPERDINE
2,5 -DIMETHOXY-,4-DIMETHYLPHENETHYLAMINE
2-METHYL-3-MORPHOLINO-1,1-
DIPHENYLPROPANECARBOXYLIC ACID
1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID
4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL
ESTER (norpethidine)
(b) any 5,5 disubstituted barbituric acid
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
COMMENCEMENT DAY NOTICE 1993
1989 Revision 7
(c) any compound (not being a compound for the time being
specified in sub-paragraph (a) above) structurally derived
from tryptamine or from a ring-hydroxy tryptamine by
substitution at the nitrogen atom of the sidechain with one
or more alkyl substituents but no other substituent;
(d) any compound (not being methoxyphenamine or a
compound for the time being specified in sub-paragraph (a)
above) structurally derived from phenethylamine, an N-
alkylphenethylamine, -methylphenethylamine, and N-
Alkyl -methylphenethylamine, or an N-alkyl -
ethylphenethylamine by substitution in the ring to any
extent with alkyl, alkoxy, alkylenedioxy or halide
substituents, whether or not further substituted in the ring
by one or more other univalent substituents.
(e) any compound (not being a compound for the time being
specified in sub-paragraph (a) above) structurally derived
from fentanyl by modification in any of the following ways,
that is to say,
(i) by replacement of the phenyl portion of the
phenethyl group by any heteromonocycle
whether or not further substituted in the
heterocycle;
(ii) by substitution in the phenethyl group with
alkyl, alkenyl, alkoxy, hydroxy, halogeno,
haloalkyl, amino or nitro groups
(iii) by substitution in the piperidine ring with alkyl
or alkenyl groups;
(iv) by substitution in the aniline ring with alkyl,
alkoxy alkylenedioxy, halogeno or haloalkyl
groups;
(v) by substitution at the 4-position of the piperidine
ring with any alkoxycarbonyl or alkoxyalkyl or
acyloxy group;
(vi) by replacement of the N-propionyl group by
another acyl group;
MISUSE OF DRUGS (CONTROLLED DRUGS) ORDER 1996
8 1989 Revision
(f) any compound (not being a compound for the time being
specified in sub-paragraph (a) above) structurally derived
from pethidine by modification in any of the following ways,
that is to say.
(i) by replacement of the 1-methyl group by an acyl,
alkyl whether or not unsaturated, benzyl or
phenethyl group, whether or not further
substituted;
(ii) by substitution in the piperidine ring with alkyl
or alkenyl groups or with a propano bridge,
whether or not further substituted;
(iii) by substitution in the 4-phenyl ring with alkyl,
alkoxy, aryloxy, halogeno or haloalkyl groups;
(iv) by replacement of the 4-ethoxycarbonyl by any
other alkoxycarbonyl or any alkoxyalkyl or
acyloxy group;
(v) by formation of a N-oxide or of a quaternary
base.
2. Any stereoisomeric form of a substance for the time being
specified in paragraph 1 not being dextromethorphan or
dextrorphan.
3. Any ester or ether or a substance for the time being specified in
paragraph 1 or 2.
4. Any salt of a substance for the time being specified in any of
paragraphs 1 to 3.
5. Any preparation or other product containing a substance or
product for the time being specified in any of paragraphs 1 to 4.
Made this day of 1996
Minister of Health and Social Services
